Sargent Investment Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.58M Sell
6,066
-373
-6% -$378K 0.73% 29
2025
Q4
$6.92M Sell
6,439
-137
-2% -$131K 0.87% 26
2025
Q3
$5.02M Buy
6,576
+1,435
+28% +$1.07M 0.72% 34
2025
Q2
$3.84M Buy
5,141
+1,448
+39% +$1.13M 0.52% 42
2025
Q1
$3.05M Buy
3,693
+1,154
+45% +$960K 0.49% 45
2024
Q4
$2.02M Sell
2,539
-87
-3% -$72K 0.33% 63
2024
Q3
$2.33M Buy
2,626
+63
+2% +$56.6K 0.42% 51
2024
Q2
$2.32M Buy
2,563
+264
+11% +$211K 0.47% 49
2024
Q1
$1.79M Buy
2,299
+138
+6% +$98.2K 0.39% 54
2023
Q4
$1.26M Sell
2,161
-290
-12% -$169K 0.28% 72
2023
Q3
$1.32M Buy
2,451
+137
+6% +$70.6K 0.32% 63
2023
Q2
$1.09M Buy
2,314
+152
+7% +$63.7K 0.26% 76
2023
Q1
$758K Buy
2,162
+33
+2% +$11.1K 0.2% 92
2022
Q4
$779K Buy
2,129
+25
+1% +$8.86K 0.24% 86
2022
Q3
$701K Sell
2,104
-115
-5% -$36.4K 0.22% 88
2022
Q2
$719K Sell
2,219
-130
-6% -$39K 0.22% 89
2022
Q1
$673K Hold
2,349
0.17% 100
2021
Q4
$649K Sell
2,349
-80
-3% -$20.3K 0.15% 105
2021
Q3
$561K Hold
2,429
0.14% 108
2021
Q2
$558K Sell
2,429
-20
-0.8% -$4.02K 0.13% 112
2021
Q1
$458K Buy
2,449
+150
+7% +$29.3K 0.12% 122
2020
Q4
$388K Hold
2,299
0.12% 126
2020
Q3
$340K Buy
2,299
+200
+10% +$31K 0.12% 117
2020
Q2
$343K Buy
2,099
+485
+30% +$74.4K 0.13% 110
2020
Q1
$224K Buy
+1,614
New +$222K 0.1% 126

Other funds holding LLY

Sargent Investment Group's LLY Position: Q1 2026 in Review

Sargent Investment Group reduced its Eli Lilly (LLY) stake by 5.8% in Q1 2026, selling an estimated $378K and leaving 6,066 shares worth $5.58M. The position accounts for 0.73% of the portfolio, ranked #29.

Sargent Investment Group first reported a position in LLY in Q1 2020 and has held it in 25 quarters since. The position peaked at $6.92M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Sargent Investment Group held 6,066 shares of Eli Lilly worth $5.58M as of Q1 2026.
  • Sargent Investment Group sold 373 Eli Lilly shares in Q1 2026, an estimated $378K.
  • Eli Lilly made up 0.73% of Sargent Investment Group's portfolio in Q1 2026, its #29 holding.
  • Sargent Investment Group first reported a position in Eli Lilly in Q1 2020 and has held it in 25 quarters since.
  • Sargent Investment Group's Eli Lilly position peaked at $6.92M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Sargent Investment Group's 13F filing for Q1 2026, filed 11 May 2026.